CRB-701 Receives FDA Fast Track Designation for Relapsed/Refractory Cervical Cancer
The FDA granted fast track designation to CRB-701 for the treatment of adult patients with relapsed/refractory metastatic cervical cancer.
Related Articles
Lisaftoclax Plus Pd Yields High ORRs and Shows Encouraging Safety Profile in RRMM
The BCL-2 inhibitor lisaftoclax was well tolerated and produced encouraging responses in relapsed/refractory multiple myeloma when given in combination with Pd.
3 Things You Should Know About Hemolytic Anemias
Hemolytic anemias are a collection of rare but severe diseases including paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Registration | Society of Gynecologic Oncology
The SGO Annual Meeting on Women’s Cancer® is the premier educational and scientific event for professionals dedicated to advancing gynecologic cancer care. It brings together…
Exploring a New Generation of Patient-Centric Cancer Clinical Trials
Register for Exploring a New Generation of Patient-Centric Cancer Clinical Trials, a virtual patient advocacy event hosted by the AACR.
CAR-T cell therapies for T cell malignancies: does cellular immunotherapy represent the best chance of cure?
Chimeric antigen receptor T cell (CAR-T) therapy has proven successful for B cell lymphomas and leukaemias. This success has inspired the development of CA
ASTCT Learning Center: Pharmacy HCT Core Topics Connection Live Session – HCT Complications and Infectious Diseases in HCT
The Pharmacy HCT Core Topics Connection Live Session will air on Thursday, January 9, at 2:00 – 3:00 pm CST. This live session will focus…
Ga 68 PSMA-11 in BgRT: Targeting Bony Metastases in Prostate Cancer
Chunhui Han, PhD, discusses the use of of Gallium 68 PSMA-11 in biology-guided radiotherapy and whether or not the radiotracer can improve the targeting and…
Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity
Ma et al. identify P4HA1 as a critical regulator of CD8+ T cell activity in solid tumor microenvironment. P4HA1 induction in CD8+ T cells causes mitochondrial dysfunction and…
OCE Conversations on Cancer – Cervical Cancer Treatment Innovation: A Collaborative Discussion
Take this survey powered by surveymonkey.com. Create your own surveys for free.
